Preimplantation Genetic Diagnosis Market, By Type (Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single-gene disorders, HLA Typing, Gender Selection, Others (for disability, adult-onset disease)), By End User (Diagnostic Laboratories, Hospitals, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share Outlook, and Opportunity Analysis, 2020 – 2027
A preimplantation genetic diagnosis can be used to examine for aneuploidy in patients with a poor prognosis who choose in vitro fertilization. It is also useful in detecting inherited single gene abnormalities, X-linked disorders, and, more recently, late-onset illnesses.
Statistics:
The global preimplantation genetic diagnosis market was worth US$ 53.5 million in 2020 and is expected to grow to US$ 81.6 million by 2027.
Global Preimplantation Genetic Diagnosis Market: Drivers
The rising prevalence of genetic disorders is expected to drive the global preimplantation genetic diagnosis market growth during the forecast period. According to the report, ‘Estimating Nationwide Prevalence of Live Births with Down’s Syndrome and Their Medical Expenditures in Korea,’ issue of the Journal of Korean Medical Science in August 2019, the incidence of babies born with Down syndrome was 5.03 for every 10,000 births during 2007 and 2016.
Furthermore, the growing number of fertility clinics is expected to fuel the global preimplantation genetic diagnosis market growth over the forecast period. For instance, Oregon Reproductive Medicine, a fertility center in November 2018 opened the ORM South in Tigard, Oregon.
To get a Free Sample Copy of COVID-19 Impact Analysis Report: https://www.coherentmarketinsights.com/insight/request-sample/698
Statistics:
Chromosomal Abnormalities accounted for the largest share in the global preimplantation genetic diagnosis market in 2019, contributing for 20.1% of market share, trailed by X-linked diseases and Aneuploidy.
Global Preimplantation Genetic Diagnosis Market: Restraints
The lack of transferable embryos is expected to hamper the global preimplantation genetic diagnosis market growth over the forecast period. The absence of normal transferable embryos occurs in nearly one-third of couples who choose preimplantation genetic diagnostic cycles. This could be due to the fact that some women have a weak response to ovarian stimulation, resulting in fewer eggs being produced. In other instances, despite the abundance of a sufficient number of embryos, the chromosomal value is continuously abnormal.
Furthermore, couples who have previously failed in IVF or preimplantation genetic diagnostic cycles have very poor potential for future success. These drawbacks hinder the global preimplantation genetic diagnosis market growth over the forecast period.
Global Preimplantation Genetic Diagnosis Market: Opportunities
The use of preimplantation genetic diagnosis in oncology is expected to provide attractive growth prospects for major players in the global preimplantation genetic diagnosis market. Preimplantation genetic testing can reduce the possibility of conceiving a cancer-affected pregnancy. It can aid in determining the embryo’s gender, and only genetically compatible embryos will be placed, allowing a healthy pregnancy to be conceived.
Furthermore, advancements in DNA technology will enhance the precision of preimplantation genetic diagnosis, boosting the global preimplantation genetic diagnosis market growth over the forecast period.
The global preimplantation genetic diagnosis market was worth US$ 50.3 million in 2019 and is expected to increase to US$ 81.6 million by the end of 2027, growing at a CAGR of 6.2% during the forecast period 2020 – 2027.
To get PDF Brochure of COVID-19 Impact Analysis of Report: https://www.coherentmarketinsights.com/insight/request-pdf/698
Market Trends/Key Takeaways
Key players in the global preimplantation genetic diagnosis market are focusing on the introduction of new products in order to diversify their product range. For instance, Agilent Technologies Inc. launched OnePGT, a genome-wide next-generation sequencing (NGS) system for preimplantation genetic testing, in December 2018.
Furthermore, the expanding network of fertility clinics is expected to propel the global preimplantation genetic diagnosis market growth over the forecast period. For instance, Prelude Fertility collaborated with NYU Langone Health in October 2018 to open the NYU Langone Fertility Center.
Global Preimplantation Genetic Diagnosis Market: Competitive Landscape
Some of the key players contributing to the global preimplantation genetic diagnosis are Reproductive Genetics Institute, Inc., Laboratory Corporation of America Holdings, PerkinElmer, Inc., Abbott Laboratories, CombiMatrix Corporation, F. Hoffman-La-Roche Ltd, CooperGenomics Inc., Quest Diagnostics, Thermo Fisher Scientific, Inc., Invitae Corporation, Vertex, Genentech Inc., Natera Inc., Illumina, Inc., Amgen, and Genea Ltd.
Global Preimplantation Genetic Diagnosis Market: Key Developments
Key players in the global preimplantation genetic diagnosis market are focusing on partnerships and collaborative approaches to increase their market position. For instance, Thermo Fisher Scientific in July 2020 announced a collaboration with First Genetics JCS, a manufacturing company of diagnostic devices and IVD kits aimed at advancing molecular genetic technologies into clinical practice, to commercialize next-generation sequencing (NGS)–based diagnostics in Russia.
To Direct Purchase of this Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/698
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- Market Dynamics
- Global Preimplantation Genetic Diagnosis Market, By Type, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Chromosomal Abnormalities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Aneuploidy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- X-linked diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Single gene disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- HLA Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Gender Selection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Others (for disability, adult onset disease)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Introduction
- Global Preimplantation Genetic Diagnosis Market, By End User, 2016 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837